GW274150 phosphate is primarily researched for its potential therapeutic applications in medical fields. It is known for its role as a selective inhibitor of inducible nitric oxide synthase (iNOS), which makes it a candidate for treating conditions associated with excessive nitric oxide production. This includes inflammatory diseases, such as arthritis, and neurodegenerative disorders like Parkinson's disease. Additionally, it has been studied for its potential in reducing tissue damage and inflammation in conditions like sepsis and stroke. Its ability to modulate nitric oxide levels also makes it a subject of interest in cardiovascular research, particularly in managing conditions linked to vascular dysfunction. Ongoing studies continue to explore its efficacy and safety in these areas.